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Solid-phase microextraction (SPME) was recently successfully automated in multi-well plate 
format in order to meet the goals of high-throughput clinical, pharmaceutical and environmental 
analysis. The technique can be used for accurate quantitation of variety of non-volatile analytes 
such as drugs, metabolites, environmental contaminants and mycotoxins, making it ideally 
compatible with  liquid chromatography-mass spectrometry applications, although recent 
applications in combination with gas chromatography and ambient mass spectrometry have also 
been reported. This review will summarize different formats of high-throughput multi-well 
SPME including fibre, thin-film and in-tip configurations.  The advantages and disadvantages of 
the technique in each format will be critically discussed with the particular focus on its fit within 
the fields of regulated analysis. The capability of high-throughput SPME will be placed in the 
context of other micro sample preparation techniques such as micro solid-phase extraction in 
order to aid the reader in the selection of the most appropriate technique for a given application. 
New developments of the devices such as monolithic and biocompatible extraction phases will 
be covered. Finally, selected applications of the technique including the analysis of whole blood 
samples and automated binding studies will be presented. 
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Highlights: 
 Recent strategies for automation of SPME in multi-well plate format are described 
 Automated 96-well SPME provides the highest throughput of SPME to date 
 Best configuration of automated SPME critically depends on the application objectives 
 Whole blood and waste effluents are directly compatible with no sample pre-treatment 
 Monolithic and biocompatible coatings address the historical limitations of SPME  
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Abbreviations: 
Desorption electrospray ionization (DESI) 
Food and Drug Administration (FDA) 
Gas chromatography-mass spectrometry (GC-MS) 
Limit of detection (LOD) 
Liquid chromatography-mass spectrometry (LC-MS) 
Liquid-liquid extraction (LLE) 
Lower limit of quantitation (LLOQ) 
Microextraction by packed sorbent (MEPS) 





Solid-phase extraction (SPE) 
Solid-phase microextraction (SPME) 
Thin-film microextraction (TFME) 
 
1.0 Introduction 
Sample preparation remains one of the main bottlenecks in modern high-throughput analysis by 
liquid chromatography-mass spectrometry (LC-MS). With the increased adoption of ultra-high 
pressure liquid chromatography and other fast chromatographic approaches such as very short 
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columns, monolithic stationary phases and/or fused-core particle technologies, the 
chromatographic separation and MS detection steps can be routinely carried out on 1-5 min time 
scale, with even sub-minute separations reported to date. This speed and increased sample 
throughput place stricter demands on fast and automated sample preparation methods, in order to 
meet the desired goals of accurate and efficient analysis of hundreds or even thousands samples 
per day. 
Solid-phase microextraction (SPME) is an equilibrium extraction technique whereby a small 
amount of extraction phase is immobilized on a solid support and used to extract/preconcentrate 
analytes of interest [1]. The most popular and widely used configuration of SPME is fibre 
geometry where extraction phase is immobilized as a thin layer on the outside of fused silica or 
metal wire support. However, SPME can also easily be performed using other configurations 
such as coated well, coated stir-bar (known as stir bar sorptive extraction), coated thin film 
(known as thin-film microextraction (TFME)) and coated capillary column (known as in-tube 
SPME) as discussed in detail elsewhere [1-3]. The main difference between SPME and more 
commonly used solid-phase extraction (SPE) methods is the ratio of sorbent versus sample 
volume [1]. In SPME, an extremely small amount of sorbent is used in comparison to sample 
volume, so exhaustive extraction analyte does not take place. Typically in SPME, only small 
portion of the analyte is extracted from the sample, and the amount of the analyte extracted 
increases with increasing extraction time until equilibrium is established between sample 
solution and extraction phase when no further increases in the amount extracted will be observed 
within experimental error. In contrast, the goal of SPE technique is the exhaustive extraction of 
all the analyte from the sample, so large amount of sorbent is used. Micro-SPE (µSPE) is simply 
a miniaturized version of SPE, whereby smaller amount of sorbent is used than in conventional 
SPE in order to be compatible with handling of smaller sample volumes, but the goal still 
remains exhaustive extraction of all analyte from the samples. Therefore, SPME and µSPE are 
conceptually distinct and not interchangeable terms. A second important difference between 
SPME and SPE methods is that most configurations of  SPME (except in-tube SPME) rely on an 
open bed configuration where sorbent is immobilized on the solid support which makes SPME 
methods more compatible with direct extraction of heterogeneous and particulate-containing 
samples. However, with the recent developments in various techniques, the lines between 
exhaustive and microextraction techniques can become increasingly more blurry – for instance, 
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in simple matrices such as buffer or urine, the extraction efficiency of thin-film configuration of 
SPME can approach the exhaustive recoveries achieved in µSPE (see section 3.0). The 
development of new configurations such as disk and pipet tip formats of SPE and in-tip SPME as 
well as the increased use of SPE-type sorbents to prepare SPME coatings also further blurs the 
lines between SPME and other solid-phase extraction techniques, making absolute recovery 
studies mandatory to determine whether exhaustive extraction is achieved in a given application 
with the selected format of extraction device.  
 
To meet the demands of high-throughput analysis, traditional techniques such as liquid-liquid 
extraction (LLE) and SPE have been fully automated in multi-well plate format to enable rapid 
parallel preparation of 96 and/or 384 samples [4]. In contrast, the historical efforts to automate 
SPME in combination with LC primarily focused on the development of online configurations, 
mainly in-tube SPME [5-7]. In this configuration, the samples are extracted with a coated 
capillary column using a series of draw/eject cycles automated via the use of the commercial 
HPLC autosamplers prior to direct online separation and analysis, and samples are processed in 
sequential manner [7]. Considering the slow kinetics of extraction and desorption steps in liquid-
phase, and the sequential approach to extraction, in-tube SPME  cannot provide sample 
throughput of the magnitude required for demanding high-throughput applications, although 
excellent performance can be achieved for a wide variety of low- to medium-throughput 
automated applications [8]. One approach to address the slow liquid-phase kinetics is to perform 
massively parallel extraction/desorption on a large number of samples, which drastically reduces 
sample preparation time per sample, permitting easy coupling with even the fastest 
chromatographic methods. This type of full automation of SPME in multi-well plate format was 
successfully completed only in 2008 [9,10], and this novel configuration has not yet gained 
widespread acceptance versus traditional single fibre or in-tube SPME approaches. Thus, SPME 
as well as other microextraction approaches such as liquid-phase microextraction remain 
extremely underutilized in the field of high-throughput analysis even though microextraction 
format can provide significant advantages over classical methods including reduced solvent 
usage, low cost and reusability, improved selectivity and compatibility with small volume 
samples. 
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The objective of this review is to critically discuss the different approaches to automate SPME in 
multi-well plate format, and present the advantages and limitations of the available 
configurations, thus extending the discussion of SPME automation beyond brief discussion 
available in recent general SPME reviews [2,10,11]. The success of the technique relies heavily 
on the properties of the coatings used to build the SPME device, so critical discussion of 
progress and challenges in this important research area will be provided. Furthermore, method 
development strategies when moving from single fiber to multi-fiber configurations will be 
briefly examined. Finally, recent applications of high-throughput SPME in clinical, 
pharmaceutical, toxicological and environmental fields will be highlighted including a brief 
discussion of novel possible future applications such as metabolomics and/or untargeted 
screening applications. 
2.0 96-well plate SPME configurations and devices 
 
To date SPME has been successfully automated in three main configurations (i) fibre, (ii) thin 
film and (iii) in-tip SPME. Thin-film configuration is commercially available as Concept96 
SPME robotic sample preparation station from PAS Technology (Magdala, Germany), while in-
tip configuration can be automated using existing laboratory automation systems such as Tomtec 
Quadra 96 (Hamden, Connecticut, US). Finally, multi-well sample desorption has also been 
developed for in vivo SPME to increase the overall throughput of this type of application. 
 
2.1 Fibre SPME configuration  
The earliest proof-of-concept reports of successful manual or semi-automated SPME 
configurations for use with multi-well plate format relied on a simple array of commercial fibers 
placed in custom-made devices designed to hold the fibers over the commercial 96-well plate 
[12,13]. Although this approach performed well, the high cost of single commercial fibers makes 
the building of 96-fibre device extremely cost-prohibitive. For this reason, the latter study also 
investigated three alternative low-cost configurations and compared their performance against 
the array of commercial devices [13].  The authors found that a simple commercial pin-tool 
replicator provided an excellent metal framework to use as solid support of SPME fibers, while 
commercially available polydimethylsiloxane (PDMS) medical grade silicone tubing provided an 
easy-to-prepare and extremely low cost SPME coating. In addition, this study clearly 
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demonstrated the importance of uniformity of agitation for automated SPME applications, and 
established the orbital agitation whilst holding SPME device stationary to be the most suitable 
agitation method (versus sonication and magnetic stirring) for the design of fully automated 
SPME systems. The main issues with the use of PDMS coatings were extremely long extraction 
times needed to reach equilibrium due to high thickness of the material, and limited types of 
analytes that could be extracted using this simple extraction phase. 
 
The subsequent study focused on (i) achieving full automation of the entire SPME procedure (ii) 
increasing the robustness of the system with particular focus on resolving the issues of fibre 
bending during robotic manipulations and (iii) developing flexible coating procedures that can 
yield thin coatings and be compatible with a wide variety of sorbents to increase the types of 
chemistries accessible by automated SPME system [9].  The full automation of SPME procedure 
was achieved using a newly developed Concept 96 robotic station shown in Figure 1B. The 
commercial version of this  system consists of an XYZ arm capable of manipulating 96-fibre (or 
thin-film) device, 3 orbital agitators (for pre-conditioning, extraction and desorption), one 
stationary wash station, XYZ syringe arm for dispensing internal standards or desorption and 
reconstitution solvents, and  96-well nitrogen blowdown device for evaporation/reconstitution. 
The use of this robotic station allowed for the automation of all sample preparation steps, 
including the addition of an internal standard, coating preconditioning, SPME extraction and 
desorption for a preset amount of time with controlled agitation and an optional 
evaporation/reconstitution step, all user-programmable with full software control.  The typical 
automated SPME protocol involves the following main steps (i) movement of 96-fibre device to 
preconditioning position (position 2 in Figure 1B) by changing XYZ coordinates of the main 
robotic arm (ii) lowering of fibres into wells containing preconditioning solvent by changing Z 
position of the main arm and computer-controlled agitation for pre-set amount of time at selected 
agitation speed (iii) dispensing preselected volume of internal standard to sample wells (position 
4 in Figure 1B) using syringe arm and agitation for preselected amount of time to mix the 
contents (iv) positioning of 96-fibre device in extraction position (position 4 in Figure 1B) by 
changing XYZ coordinates of the main robotic arm (v) lowering of fibres into wells containing 
samples by changing Z position of the main arm and computer-controlled agitation for pre-set 
amount of time at selected agitation speed to perform equilibrium or pre-equilibrium extraction 
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(vi) movement of 96-fibre device to stationary wash station (position 3 in Figure 1B) (vii) 
lowering and raising 96-fibre device 2-3 times to briefly rinse the fibres by changing Z 
coordinates of the main arm (10-30s total rinse times) (viii) movement of 96-fibre device to 
desorption position (position 5 in Figure 1B) by changing XYZ coordinates of the main robotic 
arm (ix) lowering of fibres into wells containing desorption solvent by changing Z position of the 
main arm and computer-controlled agitation for pre-set amount of time at selected agitation 
speed to perform desorption step of SPME (x) (optional) movement of 96-well nitrogen 
blowdown device to desorption position and activation of nitrogen stream to evaporate the 
desorption solvent and (xi) reconstitution of the well contents by dispensing selected volume of 
reconstitution solvent to the wells using syringe arm and computer-controlled agitation for pre-
set amount of time at selected agitation speed to redissolve the well contents. Although the 
original device also contained HPLC injection port for direct online coupling with LC-MS, this 
feature was subsequently eliminated, as the majority of commercial LC autosamplers can easily 
handle 96-well plates, thus freeing the unit to prepare new batches of samples while first batch is 
running. 
One critical aspect for achieving the successful full automation of SPME described above was 
increasing the diameter of the fibre metal support which greatly increased mechanical robustness 
of the system by eliminating fibre bending, and also improved inter-fibre reproducibility during 
coating procedure.  This optimized multi-fiber device is shown in Figure 1A and relies on thick 
metal rods (1.55 mm diameter) which were coated by immobilization of a single layer of SPE 
sorbent using strong UV adhesive (see Section 2.6). Second key aspect of ensuring good 
performance of automated SPME was good uniformity of agitation throughout the extraction and 
desorption steps in all wells. Using 850 rpm agitation, it was clearly shown that extraction time 
required to reach equilibrium was the same for all wells with no well dependence in the amount 
extracted. This permits the use of this automated system for both equilibrium and pre-
equilibrium SPME methods with excellent method precision. Although Concept96 as described 
above fully automates all steps of SPME, future improvements to the system may include 
addition of temperature control during extraction and desorption steps, and integration of the 
system with 96-well plate liquid dispensing robotic equipment to facilitate rapid parallel 
dispensing of desorption and reconstitution solvents.  
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2.2 Thin-film microextraction (TFME) configuration 
Very soon after the introduction of the multi-fiber device shown in Figure 1A, further 
modifications into changing the geometry from rod to thin-film were investigated in order to 
further increase the sensitivity of the system by increasing the surface area of the extraction 
phase [14,15].  The use of Empore extraction disks (0.5-0.75 mm polytetrafluoroethylene (PTFE) 
membrane disk saturated with fine bonded silica SPE particles) was found to have good 
extraction efficiency, but the movement of the extraction phase during the extraction was found 
problematic and adversely impacted method precision, so this particular configuration was not 
further pursued [14]. The novel rigid metal-based thin-film design shown in Figure 1C was 
found to outperform the fiber geometry, and is the preferred design in current commercial 
automated Concept96 SPME system [15]. This new configuration significantly improved 
extraction efficiency due to the increased extraction phase volume (~ 2-fold for initial design[15] 
and ~3.5-fold in finalized design [16]) and increased the initial rate of extraction (~ 2-fold) 
because of the increased surface area and the blade design of the solid support, both of which 
contributed to the more effective agitation/mass transfer (Table 1). The time required to reach 
equilibrium was also slightly shortened with TFME geometry [15]. Thus, although the 
terminology in literature may cause some confusion TFME or “blade” design of SPME simply 
implies change in geometry from well-known rod or fibre geometry to thin rectangular flat 
surface geometry as clearly visible when comparing Figures 1A and 1C, whereas the 
fundamental principles of the extraction and method optimization remain the same regardless of 
which configuration is used. All the remaining details of how automation is achieved are exactly 
the same as described in previous section. 
 
The flat shape and appropriate dimensions (50 mm length, 2.5 mm width, depth 0.7 mm) of 
TFME configuration have recently enabled a very exciting new application of the technique 
where offline solvent desorption is replaced with online desorption using desorption electrospray 
ionization  (DESI) for direct MS detection without chromatographic separation [17]. In this 
approach, individual thin films are taped onto a glass slide and placed on a moving stage 
platform, and desorption is performed by directing pneumatically assisted spray of solvent (7 
µL/min) over approximately 9 mm portion of the coating (Figure 1D). The desorption of one 
side of the coating is used for the analysis in positive ionization mode, while the second side of 
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coating is used for negative ionization mode.  Although the extraction in this study was 
performed using manual approach, automated extraction can also easily be employed for future 
applications. In addition to unprecedented sample throughput, this coupling of TFME with DESI 
resulted in improved sensitivity when compared to classical SPE-LC-MS using the same sample 
volume of wastewater effluent. Therefore, coupling of TFME with ambient desorption methods 
appears to be an extremely promising research direction, with significant expected growth. 
 
2.3 In-tip SPME configuration  
Full automation of SPME using an in-tip configuration was also recently successfully developed 
by Xie et al. [18-20]. In this format, SPME fiber is placed inside a disposable pipet tip and held 
in place with an appropriate polyethylene frit. The first array of devices used commercially 
available polydimethylsiloxane-divinylbenzene (PDMS-DVB) fibers from Supelco [18] and is 
also known as fibre-packed in-tip SPME configuration. Subsequent devices utilized monolithic 
extraction phases prepared in situ and which provided enhanced extraction efficiency [19,20]. 
This configuration is also referred to as sorbent-packed in-tip SPME and is illustrated in Figure 
1F. The existing laboratory liquid-handling systems that can handle pipet tips, such as Tomtec 
Quadra 96, can then easily be user-programmed to automate all steps of SPME extraction in 
combination with this in-tip format, thus providing easy implementation of SPME without need 
for dedicated instrumentation (Figure 1F). To implement automated in-tip SPME 96-well sample 
extraction, desorption, wash and waste plates and reservoirs containing desorption, wash and 
preconditioning solvents are placed on Tomtec Quadra. The user-written program then directs 
the automated in-tip SPME sequence including: (i) loading of the in-tip SPME pipet tips, (ii) tip 
preconditioning (iii) extraction (iv) wash (v) desorption and (vi) nitrogen evaporation and 
reconstitution.  Coating preconditioning, as well as sample extraction and desorption are 
performed using a series of aspirate/dispense cycles, similar to what is classically used for in-
tube SPME configuration. The speed of aspiration was not found to affect the method precision, 
so the highest speed settings are typically used for fastest throughput [18]. Thus, this SPME 
configuration successfully eliminates the issues with uniformity of agitation that can be 
encountered with other multi-well agitation methods. Typically, wash and conditioning steps are 
performed with 2-3 cycles, while extraction and desorption steps are performed using 10-20 
aspirate/dispense cycles.  
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2.4 96-well plate desorption of in vivo devices 
Very recently, important developments in the design and applications of in vivo SPME devices 
have been made, with new hypodermic-based devices available commercially from Supelco and 
useful for a variety of in vivo applications including pharmacokinetics and pharmacodynamics, 
metabolomics and non-lethal environmental monitoring of contaminants in aquatic organisms 
[10,21,22].  These types of applications also tend to require the analysis of large number of 
samples, but the desorption step is generally performed manually in small-volume vials using 
vortex or other suitable agitation. To facilitate processing of large number of in vivo probes, 
several designs have been developed and described with the main idea to facilitate device 
transport and enable simultaneous desorption of 96 in vivo fibers in multi-well plate format [23-
25]. The newest prototype device integrates easily with the agitators of Concept 96 robotic 
station described in section 2.2 or other commercial well-plate agitators [25]. This device 
consists of (i) base which can house a 96-well plate, (ii) a fiber support and guide system which 
allows the appropriate placement of the fibers into the centres of the wells of 96-well plate 
including the exposure of the same length of coating and (iii) a protective cover. Thus, the device 
can be used for handling, storage, transportation and desorption of in vivo probes. Figure 1E 
shows the device during the desorption step of in vivo probes. The comparison of the results for 
manual extraction versus the use of this device shows excellent repeatability with % RSDs of 6-
9% for parallel multi-well desorption versus 11-14% RSD for manual desorption (n=20 fibers) of 
four drugs tested. This shows reproducible fiber positioning can improve overall method 
precision in addition to providing ~2-fold savings in time. 
 
2.5 Critical comparison of fibre SPME, TFME and in-tip automated SPME 
configurations 
The differences in the types of configurations recently developed for multi-well SPME also 
require a critical discussion of the advantages and disadvantages of each format and the types of 
applications most suitable for a given format.  When comparing in-tip versus fibre SPME or 
TFME, both techniques have very similar sample throughput with ~100-250 min required for all 
steps of sample preparation, if equilibrium extraction is used. TFME is currently the only format 
that is fully commercially available with both fully automated robotic station with full computer-
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software control and commercial 96-TFME devices. On the other hand, in-tip SPME uses 
existing laboratory automation already available in numerous laboratories  for liquid handling, 
which permits easier adoption as no dedicated SPME instrumentation is required. However, 96-
well in-tip SPME devices are not currently available commercially, thus requiring custom in-
house preparation. Secondly, in-tip configuration is not suitable for complex samples containing 
cells and particulates and/or very viscous samples: sample filtration and/or dilution is 
recommended for such samples. TFME and fibre configurations, on the other hand, are fully 
compatible with viscous and complex samples; even whole blood [9]  or waste water samples 
[17] can be analyzed without any sample pre-treatment. In-tip fibers are typically single use, 
while open-bed configuration fibers or thin films are reusable. Reusability can be a significant 
benefit from the point of view of keeping the cost of analysis per sample down. However, 
reusability can also decrease the overall sample throughput, as portion of the sample preparation 
time must be spent on adequately cleaning the extraction phase to eliminate carryover. Typical 
cleaning procedures include 30-min cleaning step in methanol/water which also serves as sample 
preconditioning step for the next extraction [9], or a separate second desorption step (40-min) 
aimed to remove any remaining analytes with stronger solvents than typically used for 
preconditioning [16,26]. When coupling SPME with DESI, carryover from the thin films was 
removed using five consecutive 15 min sonication steps in alternating methanol and acetonitrile 
solvents [17]. The carryover issue is also particularly problematic for untargeted applications 
such as metabolomics, where it is impossible to validate that any washing step employed is 
sufficient to remove traces of every single possible metabolite regardless of its chemical 
properties and/or polarity. For such demanding applications, single-use fibers are clearly 
preferred so in-tip SPME configuration is more promising for this type of analysis. Another 
important microextraction advantage that current automated Concept 96 configuration of TFME 
has lost is the compatibility with small sample volumes. Typically 0.8-1.8 mL sample volumes 
are used to meet the requirement that the entire length of the coating must be fully immersed in 
sample throughout the extraction procedure. This means that TFME is no longer ideally suited to 
sample-limited situations, and in-tip SPME is much more suited for such applications with 
sample volumes as low as 0.1 mL used successfully. Similarly, large volumes are also required 
for desorption in TFME, so analyte pre-concentration is not really achieved, unless a time-
consuming evaporation/reconstitution step is added which drastically reduces sample throughput. 
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One exception to this is the direct  desorption of TFME using DESI-MS [17], where the 
sensitivity of TFME exceeded that of SPE for the preparation of same sample volumes due to 
pre-concentration factors achieved with the use of direct desorption directly in MS source. 
Taking into consideration that the reduction in solvent use and compatibility with small volume 
extraction are the two of main driving forces for adoption of SPME in high-throughput 
laboratories versus classical techniques such as SPE and LLE, in-tip SPME configuration 
appears better suitable to meet these demands, while TFME offers improved analytical 
sensitivity and better compatibility with complex heterogeneous samples. The requirements of 
low cost and improved selectivity are easily met by both types of configurations. Figure 2 
summarizes the main advantages of each approach.  
 
2.6 Development of coatings for automated SPME: requirements and current status 
The chemical and physical properties of the coatings employed in the device design largely 
dictate sensitivity and selectivity ultimately achievable by SPME. The main requirements for the 
development of coatings for the automated multi-well systems are good mechanical robustness, 
good solvent compatibility with commonly used desorption solvents, low thickness to enable fast 
mass transfer and excellent inter-fiber reproducibility to permit accurate and precise quantitative 
analysis. To keep the low cost of analysis it is also preferable for the coatings to be reusable, if 
possible, especially for fibre and thin-film configurations where metal solid-support framework 
may be relatively costly to manufacture. In addition, for dealing with complex matrices such as 
biological fluids, food samples or wastewater and effluents, the compatibility of coating with the 
presence of biological material is crucial with the primary focus to minimize the adsorption of 
biomolecules which can impact the analyte mass transfer into the coating. Finally, the 
availability of numerous coating chemistries would facilitate easy adoption of the technique for 
various applications.  
 
However, despite the extensive research efforts in the optimization and development of new 
coatings with huge improvements achieved within the past decade as summarized in recent 
reviews [10,27,28], the commercial availability of SPME coatings both in single-fibre and high-
throughput formats lags significantly behind other solid-phase techniques such as SPE. For 
example, for high-throughput TFME, only the biocompatible octadecyl silica (C18) and mixed-
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mode octadecyl silica (C18) with strong cation exchange group coatings are currently available 
commercially [17], while single manual fibre coatings for LC applications include about five 
chemistries, some of which are not fully compatible with solvent desorption due to polymer 
swelling [29]. Even the more recently introduced microextraction by packed sorbent (MEPS) 
allows the user access to wider selection of sorbent chemistries including reversed-phase, ion-
exchange, mixed-mode and normal-phase materials than is available for SPME technique. This 
issue presents an extremely serious shortcoming in the adoption of SPME in high-throughput 
laboratories as many users are simply not interested in producing their own in-house coatings 
and presents a major obstacle for current SPME technology. Table 2 summarizes all the coatings 
employed to date in automated SPME applications, and briefly describes their main properties 
and preparation procedures. Among all of the coatings developed to date, three main trends 
predominate: (i) design of biocompatible coatings for use in complex biological samples (ii) 
design of thin coatings to improve mass transfer kinetics for increased sample-throughput and 
(iii) design of monolithic coatings for enhanced extraction efficiencies. Notably, none of the 
coatings reported to date successfully incorporates all three characteristics, opening up additional 
avenues of research for future coating improvements. 
 
2.6.1. Design of biocompatible coatings for repeated use in complex biological samples 
Polyacrylonitrile (PAN) is a known biocompatible polymer with high chemical and mechanical 
stability, making it an excellent choice for effective sorbent immobilization in automated SPME. 
The use of this polymer as adhesive and as top layer covering sorbent particles, provides  a 
surface that minimizes protein adsorption, thus effectively eliminating the issue of fibre 
“fouling” often encountered with the use of non-biocompatible coatings in complex matrices 
[30]. Although first developed for in vivo applications, PAN-based coatings represent promising 
coatings for high-throughput applications as they provide very high fibre reusability as shown in 
Table 2. 
 
Mirnaghi et al. recently compared three different methods for preparation of thin-film coatings 
for Concept 96 systems: dipping, spraying and brush-painting using octadecyl (C18) PAN coating 
as the model system for the evaluation [31]. The spraying of the particle-polymer slurry using 
flask type sprayer with nitrogen gas resulted in the most robust reusable coatings with the highest 
 15 | P a g e  
 
physical stability. The mean extraction efficiency of diazepam over 70 uses was 94% ( 4 % 
RSD) for spraying method, versus 32% ( 147% RSD) for brush painting and 16% ( 230% RSD) 
for dipping methods, indicating no extraction phase loss over repeated uses. In fact, the sprayed 
coating could also be used for 70 extractions in human plasma with no detectable loss of 
extraction efficiency, and even up to 140 uses could be achieved with small decreases in 
extraction efficiency and method sensitivity while still maintaining adequate method precision. 
The enhanced stability of sprayed coating over other preparation methods was attributed to 
improved attachment of multiple thin layers of the coating, accomplished by coating 10 
successive thin layers followed by instant thermal curing at each step. The resulting optimum 
coatings were 60 µm thick. Thinner coatings resulted in significantly decreased physical stability 
even when optimized spraying method was used. The coatings had good chemical stability, and 
performed well in pH range 2-10, while pH values outside of this range resulted in significant 
loss of coating. 
 
One historical limitation of SPME in direct extraction mode is poor extraction efficiency of polar 
compounds, so many current coating development efforts focus on addressing this shortcoming. 
As shown in Table 2, an interesting option to improve extraction of polar compounds and other 
species of interest such as mycotoxins, is carbon tape, which is commonly used to immobilize 
samples in microscopy [32]. The double-sided nature of this tape provides an easy and low-cost 
way to prepare in-house an array of 96- fibers or thin films, and excellent extraction efficiencies 
were observed for ochratoxin A in urine with almost exhaustive recoveries (66%) even when 
using pre-equilibrium extraction times. The main disadvantages of this coating are long 
extraction times to reach equilibrium necessitating use of short pre-equilibrium extractions and 
the observed fouling of extraction phase in biological matrices, so single-use of the coating is 
recommended for complex matrices.  A recent comprehensive study of 42 different types of 
SPME coatings for the extraction of 36 metabolites of varying polarity, identified several new 
coating types particularly useful to further improve the extraction of polar compounds including 
mixed-mode silica-based or polymeric sorbents, polar-modified polystyrene-divinylbenzene (PS-
DVB)  polymeric sorbents and phenylboronic acid (PBA) coatings [33]. These coatings were 
prepared using strong solvent-compatible Loctite adhesive, however the coating robustness and 
reusability when using this type of procedure decreases as the particle size of the sorbent 
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increases. This procedure performs the best for ~ 5 µm size particle immobilization, while larger 
particles (40-80 µm PS-DVB and PBA particles) may detach upon repeated use. Thus, a 
subsequent study improved immobilization procedure and robustness of PS-DVB and PBA 
coatings using previously described PAN spray coating procedure[26].  In addition, this 
procedure also improved the biocompatibility of the coatings by using PAN biocompatible 
polymer as adhesive for immobilization, and spraying an additional thin layer of PAN on top of 
the coating to ensure complete coverage of sorbent. This approach resulted in very strong and 
reusable coatings, capable of >100 extractions in plasma matrix without any loss in efficiency.  
Although, PAN-PS-DVB performed equivalently or better than PAN-PBA coating for 5 
compounds tested in this study as shown in Table 3 (no coating volume correction) and required 
2-fold shorter extraction times to reach equilibrium (60 min versus 120 min), the compounds 
selected for the comparison did not include sufficiently wide range of chemistries. With the 
broader range of analytes included in the initial study, significantly higher recovery of some 
compounds was achievable with PBA, showing it can have complementary selectivity to existing 
common SPME coatings [33]. Therefore, additional research is needed to better understand the 
extraction capability of this new PBA coating and whether or not the top layer of PAN affects  
the extraction of polar compounds. It is also important to note that PBA coating can extract  not 
only cis-diol containing analytes, but may have more broader applicability as general SPME 
sorbent via hydrogen bonding, ionic, charge transfer, Van der Waals and pi-pi interactions 
[26,33]. Also, contrary to expectations for this affinity-type coating, the influence of extraction 
and desorption pH seems to have limited influence on the performance of this coating in SPME 
format, although this may be compound-dependent and deserves further investigation. PBA 
coating showed about 2-fold lower carryover than PS-DVB, and interestingly for both coatings 
there was no evidence that polar compounds could reach equilibrium faster than non-polar 
compounds, in contrast to in vivo hypodermic devices where 5 min was found sufficient to reach 
equilibrium for a high number of polar metabolites using vortex agitation [33]. The results also 
clearly demonstrate that the use of polymeric sorbents such as PS-DVB can eliminate the need 
for preconditioning thus further increasing sample throughput in SPME methods [26]. In 
summary, the availability of both PAN-PS-DVB and PAN-PBA coatings in format compatible 
with high-throughput automated multi-well SPME presents an important advance and extends 
the capability of the technique towards much more polar classes of compounds for the first time.  
 17 | P a g e  
 
 
2.6.2 Design of thin coatings to improve mass transfer kinetics for increased sample-
throughput 
One of the major problems that remains in the development of SPME coatings is the 
reproducible production of very thin coatings, which are preferable from the point of view of 
short extraction and desorption times. As can be seen in Table 2, only three types of coating 
employed for automated SPME have thickness below 10 µm, opening up new research 
opportunities in this area. For example, a recent study reporting 8 µm thick silicate-entrapped 
porous coatings that can be custom-modified using on-fibre derivatization and that enable 
equilibrium extraction times as short as 2 min  appears to be a particularly promising direction in 
the development of thin coatings [34]. The fibers had carryover of <2% for a range of drugs 
tested. Thin porous films are also preferred for coupling with DESI for improved extraction 
efficiency and better resulting method sensitivity  with 25 µm commercial thin films used for this 
application [17]. 
 
Although to date very few successful sol-gel coatings for coupling to LC were reported due to 
problems with solvent stability, the usefulness of sol-gel procedures to prepare robust reusable 
thin coatings was investigated by Mirnaghi et al. [31]. The speed of coating (1 mm/sec) and very 
specific drying procedure with gradual increase in temperature were found to produce the most 
robust high-quality coatings without shrinkage or cracking of the coating phase, while achieving 
good solvent compatibility.  The viscosity of sol preparation (controlled through sol composition 
and aging time) and the coating speed during the dipping method, accurately controled the 
thickness of this type of coating, thus permitting reproducible preparation of very thin coatings ( 
≤ 10 µm). The surface morphology of these coatings is rougher than corresponding PAN-based 
coatings which may be problematic for some types of analyses. However, three extractions in 
whole blood showed no evidence of red blood cell attachment to the surface. The reusability of 
coating over 20 uses in plasma was successfully established, but protein adsorption on the 
surface was noted, making this type of coating less than ideal for the analysis of biological 
samples unless further refinement to the coating procedure is introduced. 
 
2.6.3 Design of monolithic coatings for enhanced extraction efficiencies 
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Monolithic SPME coatings are another very attractive type of coating for automated SPME 
systems due to their enhanced mass transfer kinetics and easy preparation with a wide variety of 
chemistries [19,20]. Monolith preparation is usually carried out via bulk free-radical 
copolymerization of a monovinyl monomer and a cross-link monomer in the presence of 
porogenic solvent and an appropriate initiator with the aid of thermal or photo irradiation. The 
porosity and surface area of the resulting polymer are critically controlled by the type and 
amount of porogenic solvent and the crosslinker percentage presenting opportunities to prepare 
highly porous coatings of prime interest in SPME. Recently, photopolymerization technique 
using ethylene glycol dimethacrylate, dimethoxy-α-phenylacetophenone and 1-decanol was fully 
optimized for the full automation of the coating procedure in 96-well plate format using a 
Tomtec Quadra 96 robotic station and compact UV lamps [19]. To prepare the tips, an array of 
96 in-tip SPME fiber modules was prepared by placing a piece of GC capillary tubing (0.02” 
outer diameter) inside commercial polypropylene pipet tips with a 2-3 mm of tubing protruding 
from the narrow opening of the tip while the top portion of the tubing is held in place using a 
polyethylene frit. This array of tips is then loaded onto Tomtec Quadra station, and the rest of the 
coating procedure is performed simultaneously for the entire 96-array of devices by aspirating 10 
µL of polymerization solution mixture followed by fast 10-min UV curing at 365 nm using UV 
lamps placed on Tomtec Quadra in a second position. The design of the devices simplifies the 
coating procedure as the placement of capillary introduces a flow channel through the polymer, 
and this capillary GC tubing is removed after coating preparation.  Another nice feature of the 
proposed coating procedure is the ability to embed SPE type sorbents during polymerization 
procedure, for example authors successfully embedded Oasis HLB 60 µm SPE particles to 
further enhance extraction efficiency of the coating. The resulting coatings provided excellent 
extraction efficiencies of 20.2% for drug candidate tested in plasma [19] and 24-29% for vitamin 
D derivatives [20]. The direct comparison of monolithic in-tip SPME versus commercial PDMS-
DVB SPME and Varian C18 µSPE showed monolithic phase recoveries can approach those of 
µSPE methods. For example, the absolute recovery using PDMS-DVB fibre was 3.3 and 12.3% 
for oxazepam and diazepam respectively, while for monolithic phase the recoveries were 13.7 
and 46.5% versus 26.4% and 73.9% recoveries obtained for non-optimized µSPE method. These 
high recoveries were attributed to the extremely high surface area available for extraction in the 
monolithic coating, and represent some of the highest extraction efficiencies obtained by SPME 
 19 | P a g e  
 
in blood-derived fluids. In addition, this study provides the first automated coating procedure for 
SPME, addressing an important need for simple and rapid preparation of large numbers of SPME 
devices. Subsequent studies also demonstrated that high recoveries of polar zwitterionic drugs 
such as impinem, cilastatin and MK-4698 could be obtained with proposed monolithic coatings 
with absolute recoveries ranging from 9.3-16% for the three compounds studied while the 
recoveries obtained with commercial PDMS-DVB or lab-made silicate-entrapped porous C18 
coatings were below 2% for all three compounds [35]. 
 
3.0 Method development considerations for high-throughput 96-well plate SPME 
Currently, there is an increased interest in developing general purpose SPME protocols, and the 
use of multi-well or in-tip geometries imposes practical limits in terms of sample volumes and 
desorption solvent volumes needed to develop an SPME application thus permitting easier 
standardization. The focus in this type of applications is expected to slowly shift towards more 
rational method design with special focus placed on decreasing the time required for all steps in 
order to achieve the best possible sample throughput.  A detailed protocol summarizing the best 
practices and considerations during method development of automated SPME/TFME methods 
including automated binding studies has been published elsewhere [36]. 
 
In contrast to traditional single-fibre method development, high-throughput automated multi-
fibre SPME development also requires evaluation of two additional parameters: inter-fibre 
reproducibility and uniformity of agitation. Depending on the type of coating procedure used, 
some coatings may have acceptable inter-fibre variability in the amount of extraction phase 
immobilized, so further corrections may not be mandatory. Table 2 summarizes typical inter-
fibre reproducibility achievable using different coating procedures. For the coatings with poorer 
(>5% RSD) inter-fibre reproducibility, the use of an appropriate calibration method is 
recommended to ensure best accuracy and precision. The recommended calibration methods for 
this purpose are the traditional calibration approaches of internal standard calibration or the use 
of constant fibre correction factor if dealing with highly reusable coatings. The newer calibration 
method of in-fibre standardization was not found to perform well with either in-fibre or in-tip 
SPME configurations [9,35]. Secondly, the evaluation of agitation uniformity is absolutely 
critical for fibre SPME and TFME applications. Generally, the highest speed not causing spilling 
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is preferred for all geometries including TFME and in vivo devices. For TFME, the agitation 
speed of 1000 rpm (2.5 mm amplitude) to 1200 rpm (1 mm amplitude) represents the best 
compromise between extraction kinetics and prevention of spilling [26]. Method precision 
improves when using higher agitation speeds and longer extraction times, thus indicating that 
uniformity of agitation at very short extraction times may not be suitable even when using highly 
reproducible orbital agitation [15]. For instance, using agitation speed of 850 rpm, extraction 
times ≥ 10 min resulted in good method precision while at 500 rpm speed acceptable precision 
could only be obtained when using ≥ 20 min extraction times [15]. This indicates that although 
automated SPME is very suitable for use in pre-equilibrium conditions, the extraction times 
selected must be sufficiently long to establish uniform agitation in all wells, so this parameter 
must be carefully considered during the method development, especially for pre-equilibrium 
methods. The effect of agitation speed on method precision was also noted for in vivo probe 
desorption, where the use of 500 rpm agitation resulted in much poorer method precision with 
RSD ≥ 15%, while the use of 1200 rpm resulted in RSDs ≤ 7.0% [25]. In contrast, in-tip 
configuration relies on highly reproducible agitation using aspirate/dispense cycles so this 
parameter does not require further optimization during in-tip SPME method development. 
 
The evaluation of absolute recovery should be investigated during the development of any SPME 
application, but is often not reported in literature. For high-throughput applications, especially 
TFME, the increase in the extraction phase volume often in fact permits exhaustive extraction of 
moderately to highly non-polar compounds in simple matrices such as buffer or water, as 
illustrated in Table 3 for the extraction of diazepam, oxazepam and caffeine using PAN-PS-DVB 
coating. In complex matrices, the absolute recovery of SPME decreases if the analyte of interest 
is bound to biomolecules present in the complex matrix, because the amount of analyte extracted 
by SPME is proportional to free concentration. For example, in Table 3 absolute recovery for 
diazepam drops to 5.3% due to high degree of binding to plasma proteins, while for sucrose the 
absolute recovery remains the same in both matrices, since no binding of sucrose takes place. 
The knowledge of absolute recovery then helps dictate whether the technique can be used for the 
determination of free concentrations and/or binding studies. For studies where such parameters 
are not of interest, absolute recovery by SPME in biological fluids can be enhanced by disrupting 
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drug binding via addition of salt, solvent or pH change to improve limits of detection achievable 
by SPME.  
 
 
4.0 Current applications of high-throughput SPME 
To date high-throughput SPME/TFME has been successfully applied in a variety of applications 
including clinical, pharmaceutical, toxicological, food and environmental analysis. Other 
applications, not exploited to date, could include tissue analysis after homogenization or analysis 
of non-volatile components or contaminants in food commodities, leaving many opportunities 
for increased development of automated SPME applications. In future, multi-well SPME 
configurations can also be used beyond targeted analyses applications such as described in this 
review to encompass the newly emerging field of metabolomics. For instance, metabolite 
profiling of plasma or blood can easily be migrated to the high-throughput platform in future for 
fast preparation of large number of samples [33].  
 
4.1 Clinical and bioanalytical applications 
In an early proof-of concept investigation of the feasibility of SPME in pharmaceutical drug 
discovery, the performance of SPME was compared with LLE using the same drug candidate 
and 0.25 mL plasma samples [12]. Intra-day precision of LLE ranged from 0.8-3.3% RSD with 
accuracy at all levels within ± 2%, while for SPME precision ranged from 0.5-6.9% RSD with 
accuracy at all levels ±5%. Both methods were successfully validated in the range of 1-500 
ng/ml according to Food and Drug Administration (FDA) guidelines [37]. The comparison of 
concentration-time profiles obtained using SPME and LLE after single-dose administration of 25 
mg of drug candidate showed excellent agreement between the two techniques. Overall, LLE and 
SPME were both suitable for the analysis of the proposed drug candidate in clinical samples, but 
SPME reduced solvent usage, eliminated the need for evaporation/reconstitution step needed for 
LLE and had overall higher sample throughput if using a full 96-fibre device. The main 
disadvantages found in this study were high carryover (>10%) requiring extensive coating clean-
up prior to reuse, limited number of coating chemistries available and high cost of building 96-
fibe device using commercial fibers.  
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Subsequent studies of the performance of high-throughput SPME in pharmaceutical discovery 
focused on in-tip SPME configurations and illustrated the promise of the technique in a variety 
of applications. For example, in-tip SPME was applied for peroxisome proliferator activated 
receptor modulated drug candidate (MK-0533) undergoing clinical investigation [18]. The intra-
day precision was 13.7% RSD at lower limit of quantitation (LLOQ) and ranged between 1.0 to 
9.1% RSD at all other concentration levels, while intra-day accuracy was within ±8% across the 
entire linear dynamic range of the method. The proposed method showed excellent agreement 
with validated LLE method routinely used for this analysis as shown in Figure 3. In-tip SPME 
was also successfully validated for the determination of drug candidate MK-0974 in human 
plasma with intra-day accuracy and precision ranging from 97.5 to 104.3%, and 3.0 to 13.0% 
RSD, respectively [19]. The method performance was compared to µSPE using the same HLB 
sorbent material, and excellent agreement was obtained between the two methods for the analysis 
of clinical samples and calculation of individual and mean pharmacokinetic parameters after oral 
administration [35]. These types of head-to-head comparisons clearly reiterate that SPME is a 
feasible alternative approach for routine drug analysis in pharmaceutical industry. In-tip SPME 
was also successfully used to develop a method for the determination of vitamin D3 in human 
serum with derivatization [20].  Intra-day accuracy ranged from 92.8 to 104.8% while precision 
(including derivatization) ranged from 2.2 to 10.9 % RSD. Unfortunately, the results of this 
study illustrate one of the recurrent limitations of SPME and other microextraction techniques 
when the analysis of ultratrace analyte concentrations is required, as SPME was not able to 
match the sensitivity achievable by LLE (0.5 ng/mL) with LOQ of 5 ng/ml for SPME. However, 
SPME method used 4-fold lower volume of human serum, had lower absolute matrix effects 
versus automated LLE method,  considerably higher sample throughput (2 hr per 96 samples) 
versus both manual (9 hr per 96 samples) and automated LLE methods (3 hr per 96 samples). 
SPME also reduced solvent use by about 5-fold versus automated LLE method, and remarkable 
34-fold versus manual LLE method. Thus, although SPME method was not found suitable for 
the determination of vitamin D3 time concentration profiles after administration of low doses, it 
provides a simple and rapid alternative for pharmacokinetic studies at higher doses. 
 
Automated TFME and Concept96 were also recently used in clinical practice for the high-
throughput determination of tranexamic acid concentrations in patients undergoing 
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cardiopulmonary bypass surgery [38,39,39]. LLOQ of the proposed method was 1 µg/mL and 
was suitable for therapeutic drug monitoring of this common antifibrinolytic agent for high-risk 
surgeries. This LLOQ could be achieved despite the 4-fold dilution to reduce the consumption of 
clinical samples and the use of C18 coating not ideally suited for the extraction of polar 
compounds such as tranexamic acid. More surprisingly, the automated TFME (270 min for 96 
samples) provided better LLOQ than protein precipitation (10 µg/mL), and ultrafiltration (2.5 
µg/mL) methods, and the gains in sensitivity were even higher considering the 4-fold matrix 
dilution used for TFME. Intra- and inter-day accuracy was ±10% and precision was ≤ 12% at all 
concentration levels tested. The mean recovery of the method was 2.38 ± 0.18%. The correlation 
coefficient between TFME and protein precipitation method was 0.82, with no statistically 
significant differences found between the two methods using t-test (p > 0.45). The Bland-Altman 
analysis of solvent precipitation versus TFME also demonstrated good agreement of the two 
techniques across clinically-relevant concentration range, showing that the two methods can be 
used interchangeably [40]. The method was subsequently used for evaluating inter-patient 
variability in drug concentrations and the suitability of the proposed dosage model [41].  This 
clinical application also represents the first successful reported high-throughput application of 
automated SPME to highly polar molecule, showing that the range of compounds accessible with 
this technique has been successfully expanded in recent years.  Also, the results of this study 
establish for the very first time the suitability of automated SPME for high-throughput clinical 
analysis representing an important first step to wider adoption of this technique in clinical 
laboratories. Although not important for this particular application, since tranexamic acid has 
negligible plasma-protein binding, automated SPME/TFME can also be used to determine both 
free and total concentrations of analytes in a single sample and using a single analysis, thus 
providing significant time savings over traditional approaches where second method, such as 
ultrafiltration is necessary if free drug concentration is of interest [42]. Such determinations of 
free drug concentration are particularly important in therapeutic drug monitoring applications of 
the drugs with narrow therapeutic index, a possible new area of application for automated SPME 
methods. 
 
Furthermore, automated SPME in fiber or thin film formats permits the analysis of whole blood 
or other complex samples without any need for sample pre-treatment. For instance, the 
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automated multi-fibre SPME of four benzodiazepines from whole blood with EDTA 
anticoagulant was fully validated, with intra-day accuracy 87-109% for all compounds and 
method precision ranging from 2-14% RSD and inter-day accuracy and method precision 
ranging from 87-115% and 1-12%  RSD respectively [9]. LLOQs obtained in the study were 4 
ng/mL, suitable for therapeutic drug monitoring of benzodiazepines, and sub-ng/mL LLOQs are 
possible if using TFME configuration [15,16] and/or newer generation of triple quadrupoles for 
MS analysis for applications where increased sensitivity is required. The entire automated SPME 
procedure required 100 min for the preparation of 96 samples, matching well the capabilities of 
multi-well SPE and LLE methods.  
 
The automated SPME can also be useful for large-scale toxicological and epidemiological 
studies of human exposure to various contaminants. For example, automated SPME with carbon 
tape coating was successfully validated to determine the concentrations of an ubiquitous 
mycotoxin, ochratoxin A, in human urine [32]. Excellent sensitivity (0.7 ng/mL LLOQ) was 
achieved while the method was extremely simple and required only pH adjustment of urine prior 
to extraction. In contrast, most other analytical methods to date for this mycotoxin required much 
more costly  and time-consuming multiple extraction and/or immunoextraction procedures, so 
automated SPME presents a much faster lower-cost alternative to classical approaches. It is also 
perfectly suited for high-throughput screening with capability to prepare >1500 samples per day 
(75 min per 96-samples). Mean intra-day accuracy and precision ranged from 93.5 to 113.7% 
and 2.1-11.5% RSD, while inter-day figures of merit ranged from 91.0-109.1% and 4.4-14.3% 
RSD respectively, thus easily meeting the requirements for regulated analysis recommended by 
FDA [37]. 
4.1.1 Ionization suppression and matrix effects 
One of the major challenges in the development of bioanalytical methods by LC-MS is to reduce 
or eliminate matrix effects which can cause ion suppression/enhancement of the analyte signal of 
interest [43,44]. SPME methods can help to address this challenge due to non-exhaustive nature 
of the extraction, which reduces the amounts of co-eluting interferences such as phospholipids, 
thus reducing the extent of ionization suppression in complex samples. Thus, SPME represents a 
useful alternative when simple low-cost methods such as protein precipitation with solvent do 
not provide sufficiently clean sample extracts and sufficient selectivity for the needs of a given 
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application. For example, in-tip SPME showed moderate sample clean-up with ~2-fold decrease 
in the amount of phospholipids co-extracted from plasma versus solvent precipitation, while LLE 
provided the  cleanest extract in a recent comparison [35]. The direct comparison of SPME and 
SPE also showed differences in the composition of co-extracted lipids, with SPE performing 
better for the removal of more hydrophobic phosphocholine lipids rather than 
lysophosphatidylcholine lipids, showing that the preferred method may strongly depend on the 
nature of analyte and co-eluting interferences. Phospholipid presence in SPME can be further 
reduced by using acetonitrile versus methanol as SPME desorption solvent. Furthermore, 
absolute matrix effects were evaluated for both in-tip and fibre/TFME configurations for a wide 
variety of analytes ranging from highly polar to highly non-polar, and no absolute matrix effects 
were observed with the values falling between 80-120%  form nominal values when comparing 
the signal of standard spiked into matrix post-extraction versus neat standard signal intensity 
[19,26,36,38]. The comparison of monolithic in-tip SPME versus C18 µSPE showed presence of 
absolute matrix effects for the latter method for the determination of benzodiazepines in human 
plasma, while the two SPME methods showed no absolute matrix effects for all analytes except 
for oxazepam-monolithic coating combination [35]. In general, significant absolute matrix 
effects are not often observed for SPME methods in combination with LC-MS unless the analyte 
elutes in the region of anticoagulant or stabilizer [33,35]  or co-elutes with an interference 
present in solvents used for desorption [29]. The use of HILIC rather than reversed-phase 
methods also increases the likelihood of encountering noticeable ionization suppression due to 
increased chromatographic co-elution in HILIC conditions [33,35]. For example, Xie reported 
significant matrix effects for cilastatin with >25% deviation from nominal concentration using 
both in-tip SPME and solvent precipitation methods of sample preparation [35]. Omitting the 
chromatographic separation step is also likely to result in noticeable absolute matrix effects for 
SPME, but even in this case SPME (50% reduction in signal) was found to outperform SPE 
(90% reduction in signal) in a recent DESI-MS study [17]. The presence of relative rather than 
absolute matrix effects is more likely to be problematic for SPME methods as small variations in 
sample composition, pH and ionic strength could slightly affect the amounts of analyte extracted 
and co-extracted interferences. However, extensive evaluations of relative matrix effects by 
comparing slopes of the calibration lines constructed in different lots of biological matrix 
indicate excellent performance of SPME with respect to this parameter, with slope RSDs of 1.4% 
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[12], 2.1% [9], 3% [19] 4.2% [20] and 4.6% RSD [32] depending on the analyte and matrix 
under study, all of which indicate methods free of relative matrix effects [43,44]. One exception 
to this general trend is HILIC LC-MS method for the determination of impinem, cilastatin and 
MK-4698 drugs in rat plasma where relative matrix effects of 10.1%, 8.8% and 10.4% were 
reported, and SPME performed more poorly than solvent precipitation (slope RSDs of 3.1-6.0%) 
[35]. Using post-column infusion experiments, the observed ion suppression and relative matrix 
effects were attributed to drug co-elution with endogenous phospholipids and/or stabilizers 
added to the samples due to the unstable nature of the drugs studied, depending on the retention 
time of the drug. In such cases, the use of deuterated internal standards is mandatory to achieve 
good method performance, and therefore, detailed evaluation of matrix effects remains an 
important parameter for investigation during development of any bioanalytical method including 
SPME-based methods. 
 
4.2 Automated binding studies 
SPME can also be used to perform automated binding studies both (i) to determine binding 
affinity between a particular receptor and ligand and/or (ii) the extent of overall binding in a 
complex matrix such as % plasma-protein binding, extent of sorption of pollutants to humic 
substances  or bioaccumulation factors [45,46]. The main principle for this type of application is 
that the amount of analyte extracted by SPME/TFME is proportional to free concentration, and 
thus SPME avoids the need to physically separate bound from unbound analyte as is done in 
classical methods of equilibrium dialysis and ultrafiltration. Among the very few automated 
methods reported for drug binding studies, 96-well equilibrium dialysis method requires 8-hr to 
reach equilibrium, severely limiting sample throughput [47] while high-throughput ultrafiltration 
assay lacks accuracy and precision for highly bund drugs [48]. Properly designed SPME methods 
can successfully address both of these limitations [36] and can be performed both under 
negligible or significant depletion conditions as discussed in detail elsewhere [45]. The 
automation of binding studies by SPME permits all points of binding curve to be prepared 
simultaneously, and 8-12 ligands can be studied simultaneously within 96-well format, providing 
drastic increase in sample throughput versus manual binding studies relying on a single fibre. An 
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in two independent studies) [49]. In addition, numerous reports of manual 
binding studies by SPME exist for a diverse range of drugs and other compounds exhibiting both 
low and high binding, including ibuprofen, warfarin, verapamil, propranolol, caffeine, estradiol, 
isosorbide dinitrite and chlorhexidine just to name a few [45,46,50-52]. Binding constants for 
multiple binding sites can also be acquired using SPME provided that a sufficient number of data 
points over a wide concentration range is acquired for the ligand [45], and the data obtained by 
SPME  can be highly complementary to other methods such as spectroscopic techniques [53]. 
Considering the importance of ligand-receptor binding studies in various fields including drug 
discovery, bioaccumulation, toxicology and ecology, it can be expected that the use of automated 
SPME methods for this type of applications may increase in future years.    
 
4.3 Environmental applications of multi-well SPME devices: coupling to GC-MS 
and DESI-MS 
Considering its inherent compatibility with the analysis of complex heterogeneous samples, 
automated TFME was recently employed to monitor selected pharmaceuticals in wastewater 
effluents from pilot-scale municipal treatment plants and wastewater-influenced river samples in 
combination with LC-MS [2,54]. The proposed method achieved limits of detection (LOD) of 2-
13 ng/L for carbamazepine, fluoxetine, sertraline, and paroxetine with good precision (<16% 
RSD), showed good agreement with accepted SPE method and was found suitable for 
monitoring of wastewater effluents.  The absolute recoveries ranged from 71 to 88% depending 
on the analyte, demonstrating nearly exhaustive recoveries achievable by TFME in some 
applications. Overall sample preparation time included 30 min preconditioning, 70 min 
equilibrium extraction and  60 min desorption.  
Although multi-well SPME configurations have been primarily developed to increase the 
throughput in combination with LC-MS studies, GC applications can also be envisaged for this 
type of technology if developing very high-throughput applications for the analysis of species of 
sufficiently low volatility. For example, the study by Hutchinson et al. showed that multi-well 
SPME using PDMS silicone tubing immobilized on rods is suitable for the analysis of less 
volatile PAHs from water such as anthracene and fluoranthene with remarkable method precision 
of 1.8% for n=96 extractions with the use of deuterated standard in 60-min total sample 
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preparation time [13]. However, significantly poorer figures of merit were obtained for more 
volatile species such as napthalene and fluorene with 37.9% RSD for naphthalene. In another 
study, Bagheri et al. used 96-well plate set-up for the extraction of selected organophosphorus 
and triazole pesticides (diazinon, penconazol, tebuconazol, bitertanol, malathion, phosalone and 
chlorpyrifos-methyl) from cucumber [55]. The equilibrium extraction (40-min) was performed 
using manual 96-fibre set-up with PDMS silicone tubing (1.0 cm) placed on stainless steel tubing 
to serve as the SPME extraction phase, while custom-made PTFE 96-well plate block was used 
in lieu of commercial multi-well plates for extraction and desorption. Desorption (5-min) was 
performed using 600 µL of acetonitrile, followed by evaporation to dryness using stream of 
nitrogen and reconstitution in 20 µL of n-octane. The carryover was less than 0.6% when using 
5-min desorption times. The method precision was found satisfactory, with the inter- and intra-
day RSDs less than 15.4%. LODs ranged from 8-60 µg/kg, and LLOQs were sufficient to meet 
regulations of European Commission.  
 
The coupling of TFME with direct online desorption by DESI-MS for environmental monitoring 
of carbamazepine and triclosan in wastewater effluents was also reported [17].  The proposed 
method showed good agreement with traditional SPE- LC-MS analysis, but SPME offered the 
advantages of short analysis times, low-cost, higher sample throughput and possibility of 
miniaturization. The method had excellent accuracy and precision, and method sensitivity of 
TFME exceeded that of SPE-LC-MS method when using the same sample volumes, thus 
showing excellent promise of the technique in environmental monitoring applications. Even 
more importantly, untargeted pharmaceutical screening could also be carried out with successful 
detection of beta blockers, UV filters, insect repellent, non-steroidal anti-inflammatory drugs and 
various surfactants. Finally, the potential of TFME to monitor temporarily high concentrations of 
contaminants in effluent streams was also evaluated, showing that TFME could be potentially 
used for process monitoring provided hourly analysis is performed. However, temporarily high 
concentrations could not be successfully detected over  longer time periods as TFME would 
respond to new analyte concentrations fairly rapidly, an important advantage of SPME often 
exploited in other types of applications such as pharmacokinetic studies [56], but a disadvantage 
in this type of process monitoring application. 
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5.0 Future perspective and new opportunities 
In summary, automated multi-well SPME/TFME provides the highest throughput of SPME to 
date. It is suitable for a wide variety of applications to non-volatile analytes including drugs, 
metabolites, vitamins, environmental contaminants, food and plant components and even 
untargeted screening and metabolomics applications. The main advantages for implementation of 
SPME in high-throughput analysis are (i) reduced use of solvents (ii) clean sample extracts 
minimizing the potential for ionization suppression (iii) low-cost (iv) similar throughput to what 
is achievable by SPE and LLE and better throughput than for online SPE methods (v) the ability 
to handle complex heterogeneous samples such as whole blood or waste effluents without 
sample pre-treatment  (vi) the ability to obtain both free and total concentrations from a single 
analysis and/or perform binding studies  and (vii) excellent compatibility with new ambient mass 
spectrometry methods such as DESI. The main disadvantages of the automated SPME are similar 
to those of all microextraction methods: (i) strict control of extraction conditions is required 
including control of pH, ionic strength and temperature to achieve best method precision, (ii) 
highly sensitive analytical instrumentation is needed for detection to compensate for non-
exhaustive analyte recovery and (iii) analytical sensitivity of SPME in direct extraction mode is 
generally lower than for classical methods thus making it an unsuitable choice for the 
development of methods requiring extremely high sensitivity. Furthermore, due to open-bed 
configuration, this technique is not suitable for volatile analytes due to evaporative losses. 
Finally, there is an inherent lack of data demonstrating reproducible and robust implementation 
of automated multi-well SPME for routine analysis due to very recent development of this 
particular configuration and extremely limited commercial availability of suitable coating 
chemistries for all SPME configurations. Until this latter issue is addressed, widespread adoption 
of SPME in direct extraction mode for high-throughput analysis cannot be expected. 
Current multi-well SPME configurations described in this review are capable of providing 
sample throughput equivalent to about 0.7-2 min per sample, and although this represents the 
highest throughput of SPME achievable to date, it still may not be enough to compete with the 
rapid progress in other techniques. For example, monolithic pipet tip SPE was recently reported 
with cycle times of 2-6 min for 96 samples [57,58]. This places increasing demands on finding 
innovative solutions to further speed up automated SPME. Such drastic improvements in speed 
of automated SPME can be accomplished through a number of ways such as the use of pre-
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equilibrium extraction times, polymeric coatings which do not require preconditioning step, very 
thin coatings to reduce extraction and desorption times, use of disposable coatings to eliminate 
the need for extraction phase cleaning and perhaps more revolutionarily moving the technique 
back to micro-scale or nano-scale dimensions to speed up extraction kinetics and permit fast 
analysis of minute sample volumes. Other opportunities in adoption of SPME in high-throughput 
analysis include automated binding studies, whole blood analysis, applications requiring 
improved sample clean-up and improved therapeutic drug monitoring assays by simultaneous 
determination of both free and total drug concentrations, the types of applications that require 
excessive sample preparation times by classical approaches or the use of multiple analytical runs. 
Finally, the coupling of automated TFME with ambient desorption techniques such as DESI 
opens up new opportunities for the design of extremely high-throughput and highly sensitive 
applications of enormous interest in environmental, food and clinical analysis. 
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List of Figures 
 
Figure 1 Different multi-well automated formats of SPME (A) multi-fiber SPME [9]  (B) 
Concept96 robotic station equipped with (1) 96-TFME device whereby (2, 4, 5) are orbital 
agitators used for preconditioning, extraction and desorption respectively, (3) is stationary wash 
station, (6) is 96-well nitrogen blowdown device, (7) is syringe arm and (8) is XYZ arm used to 
position TFME or nitrogen blowdown devices over the correct multiwell plates placed in 
positions 2-5 [36] (C) detailed picture of TFME device shown in (B) [16] (D) TFME coupling 
with DESI where (1) is an electronic sprayer, (2) is inlet capillary (3) is TFME device secured to 
the stage (4) is rotating stage (5) is sample table moveable in XYZ directions (6) is gas supply 
and (7) is solvent supply. DESI is directed over two 9-mm lengths of TFME coating and the 
resulting ions are analyzed in MS after collection into inlet capillary [17] (E) in vivo SPME 96-
well desorption device shown positioned on an orbital agitator[25] and (F) detailed picture of an 
in-tip SPME device and (G) in-tip SPME device shown attached on commercial Tomtec Quadra 
station to carry our extraction and desorption steps of SPME[19]. Figures were reprinted with 
permission of the appropriate  publisher from the references specified in brackets. 
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Figure 2 Comparison of the main advantages and disadvantages of in-tip versus TFME 
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Figure 3 Concentration-time profile of MK-0533 drug candidate in plasma of pooled healthy 
subjects after single-dose administration of 75 mg of drug using LLE and in-tip SPME 
techniques. Figure reprinted from ref. [18] with permission of Elsevier. 
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Table 1 Comparison of the extraction rates (from linear portion of extraction time profile) 
and absolute recoveries using thin-film (TFME) and fiber SPME methods on Concept 96 for 
the extraction of benzodiazepines in PBS buffer (n=96) Table reprinted from ref. [15] with 
permission of American Chemical Society. Copyright 2009. 
 
Parameter Diazepam Nordiazepam Lorazepam Oxazepam 
Recovery (%) TFME 51 45 17 20 
Recovery % SPME 30 26 12 10 
Extraction rate TFME (ng/min) 6.2 6.6 2.2 1.6 
Extraction rate SPME (ng/min) 3.4 3.5 1.3 0.94 
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Table 2 Summary of coatings and coating procedures employed to date in automated multi-well SPME systems 
 































yes (> 50 
uses) 
no yes [9,13,28,55] 
Octadecyl or C16 









yes (>15 uses) no yes [9,15,36,49] 









very high log 
P compounds 
[32] 
Empore C18 disks 
(commercial 





Cut and immobilize 
with pins 
0.5 mm no 4-6% yes no yes [14] 
Silicate-entrapped 
porous C4, C8, 
C18 and C30 
On-fiber 
derivatization of 




8 no 18.6% (n=6) 
yes 
(>100 uses) 
no yes [34] 
Octadecyl-PAN 
Biocompatible 
5 µm silica particles 
immobilized using 
PAN 
60 no 5-7 % 
yes 
(~ 70 uses in 
plasma and 
>140 uses in 
PBS) 
no  yes [16,38,54] 




Sol-gel 10 no 3.8-8.5% (n=12) 
yes 
(>100 uses in 
PBS and >20 
in plasma) 




(PS-DVB) - PAN 
Biocompatible 
PS-DVB with weak 
anion exchange group 
80 µm silica particles 
immobilized using 
PAN 
230  4.4-8.3% (n=6) 
Yes 
(>100 uses) 
yes yes [26] 
Phenylboronic 
acid (PBA) -PAN 
Biocompatible 




185 no 5.6-9.8% (n=6) 
Yes 
(>100 uses) 







Not evaluated yes no yes [12] 
In-tip SPME coatings 
PDMS-DVB 
Commercial (Supelco 
Inc.) fibers secured 
inside disposable 














SPE sorbents may be 
embedded such as 
Oasis HLB 60 µm 
particles 
n/a yes 15.4 
no 
(disposable) 
yes yes [19,20] 
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Table 3 Percent absolute recovery for PAN–PS–DVB and PAN–PBA 96-blade SPME coatings 
for equilibrium extraction (100 ng/mL diazepam, oxazepam, caffeine and riboflavin, and 300 
ng/mL sucrose spiked in PBS (pH = 7.4), and 300 ng/mL of all five compounds spiked in human 

















Diazepam 2.82 3.4 98.1 ± 4.2 5.3 ± 0.6 74.1 ± 5.5 1.5 ± 0.2 
Oxazepam 2.24 12.4 97.4 ± 3.3 6.7 ± ± 0.5 50.1 ± 2.3 1.8 ± 0.2 
Caffeine −0.07 10.4 98.9 ± 5.4 30.2 ± ± 2.1 33.7± 2.7 15.1 ± 1.5 
Riboflavin −1.46 10.2 71.4 ± 2.9 42.6 ± 3.3 44.6 ± 3.9 19.5 ± 1.8 
Sucrose −3.70 12.6 3.5 ± 0.3 3.6 ± 0.4 4.0 ± 0.4 3.8 ± 0.5 
